Chartwell Pharmaceuticals West Caldwell LLC – FDA 483, Dec 18, 2024
An FDA inspection of Chartwell Pharmaceuticals West Caldwell LLC's control testing laboratory in West Caldwell, NJ, revealed significant deficiencies in their quality control processes. Observations included failures to establish proper performance qualification studies for HPLC systems and validate associated computer software, as well as not performing routine equipment inspections according to a written program. Additionally, the firm failed to assess equipment and software validations from previous occupants and used laboratory equipment to test drug products past their calibration due dates.
ID · b98ec793-c1b4-4a59-8e5c-85f5eb0710d1
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.